Prediction of Pharmacokinetic Alterations Caused by Drug-Drug Interactions: Metabolic Interaction in the Liver
- 4 January 2025
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 50 (3) , 387-411
- https://doi.org/10.1016/s0031-6997(24)01372-3
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitorsEuropean Journal of Clinical Pharmacology, 1996
- PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKINETICSBiopharmaceutics & Drug Disposition, 1996
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapyMolecular Carcinogenesis, 1995
- In Vitro Prediction of the Terfenadine‐Ketoconazole Pharmacokinetic InteractionThe Journal of Clinical Pharmacology, 1994
- Terfenadine-Ketoconazole InteractionJAMA, 1993
- Torsades de Pointes Occurring in Association With Terfenadine UseJAMA, 1990
- Effect of Concurrent Sucralfate Administration on the Absorption of ErythromycinThe Journal of Clinical Pharmacology, 1990
- Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border and basolateral membrane vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Mechanisms of p- transport by brush-border and basolateral membrane vesicles isolated from rat kidney cortexBiochimica et Biophysica Acta (BBA) - Biomembranes, 1982
- Kinetics of drug-drug interactionsJournal of Pharmacokinetics and Biopharmaceutics, 1973